MedPath

Mindfulness-based Music Therapy in Blind Elderly Women

Not Applicable
Completed
Conditions
Elderly
Mood
Mindfulness
Music Therapy
Blind
Registration Number
NCT05583695
Lead Sponsor
The Hong Kong Polytechnic University
Brief Summary

This trial aims to examine effects of mindfulness-based music therapy on mood regulation in blind elderly women.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
90
Inclusion Criteria
  • female
  • blind with visual acuity (the best eye) of 20/400 or below
  • aged 65 years or above
  • cognitive intact, measured using Hong Kong Montreal Cognitive Assessment (6th version) with a score ≥ 12
  • able to speak Cantonese
Exclusion Criteria
  • none

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Difficulties in Emotion Regulation Scale (DERS)In the 8th week from baseline

Difficulties in Emotion Regulation Scale is a 36-item measure assessing six emotion regulation dimensions: non-acceptance, goals, impulse, strategies, clarity, and awareness. The total score ranges from 36 to 180. Higher scores represent more difficultly in regulating emotions.

Secondary Outcome Measures
NameTimeMethod
Depression Anxiety Stress Scales-21 (DASS-21)In the 8th week from baseline

Depression Anxiety Stress Scales-21 is a 21-item scale designed to assess depression, anxiety, and stress symptoms. It is divided into three subscales with each containing 7 items. Each subscale total score ranges from 0 to 21. Higher scores indicate more severe symptoms.

Geriatric Depression Scale (GDS)In the 8th week from baseline

Geriatric Depression Scale is a 30-item questionnaire asking how participants felt over the past week. The total score ranges from 0 to 30. Higher scores indicate more depressive symptoms.

Trial Locations

Locations (1)

Hong Kong Society for the Blind

🇭🇰

Kowloon, Hong Kong

Hong Kong Society for the Blind
🇭🇰Kowloon, Hong Kong

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.